Your browser doesn't support javascript.
loading
Calprotectin: two sides of the same coin.
Carnazzo, Valeria; Redi, Serena; Basile, Valerio; Natali, Patrizia; Gulli, Francesca; Equitani, Francesco; Marino, Mariapaola; Basile, Umberto.
Affiliation
  • Carnazzo V; Department of Clinical Pathology, Santa Maria Goretti Hospital, AUSL Latina, Latina, Italy.
  • Redi S; Department of Clinical Pathology, Santa Maria Goretti Hospital, AUSL Latina, Latina, Italy.
  • Basile V; Facoltà di medicina e Chirurgia, Department of Clinical Pathology, Università "La Sapienza", Rome, Italy.
  • Natali P; Clinical Pathology Unit and Cancer Biobank, Department of Research and Advanced Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Gulli F; Department of Laboratory Medicine and Pathology, Azienda Ospedaliero Universitaria e Azienda Unità Sanitaria Locale di Modena, Modena, Italy.
  • Equitani F; Clinical Biochemistry Laboratory, IRCCS "Bambino Gesù" Children's Hospital, Rome, Italy.
  • Marino M; Department of Transfusion Medicine and Immuno-Hematology, Santa Maria Goretti Hospital, AUSL Latina, Latina, Italy.
  • Basile U; Dipartimento di Medicina e Chirurgia Traslazionale, Sezione di Patologia Generale, Università Cattolica del Sacro Cuore, Rome, Italy.
Rheumatology (Oxford) ; 63(1): 26-33, 2024 Jan 04.
Article in En | MEDLINE | ID: mdl-37603715
ABSTRACT
Calprotectin (CLP) is a calcium-binding protein produced by neutrophils and monocytes in the course of inflammation. Today, the role of faecal CLP in chronic IBD is well known, but in recent years attention has shifted towards circulating CLP. In fact, this molecule can be measured in different biological fluids blood, saliva and urine, using different analytic methods that are described in this review. Furthermore, different data confirm the relevant role of serum CLP in autoimmune diseases. In this review we will highlight the correlation between high levels of circulating CLP and specific autoantibodies of major autoimmune pathologies paving the way to the employment of CLP measurement as useful biomarker for monitoring outcome in different pathologies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Leukocyte L1 Antigen Complex Limits: Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2024 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Leukocyte L1 Antigen Complex Limits: Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2024 Type: Article Affiliation country: Italy